Market Cap 1.19B
Revenue (ttm) 911.98M
Net Income (ttm) 145.42M
EPS (ttm) N/A
PE Ratio 16.69
Forward PE 47.33
Profit Margin 15.95%
Debt to Equity Ratio 0.00
Volume 1,131,000
Avg Vol 1,157,162
Day's Range N/A - N/A
Shares Out 28.81M
Stochastic %K 21%
Beta 0.83
Analysts Sell
Price Target $54.33

Company Profile

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for patients with moderate to severe OSA. It also develops a novel, closed-loop solution that continuously monitors a patient's breathing and delivers mild hy...

Industry: Medical Devices
Sector: Healthcare
Phone: 844 672 4357
Address:
5500 Wayzata Blvd., Suite 1600, Golden Valley, United States
nUme22
nUme22 May. 29 at 7:20 PM
$INSP buying
0 · Reply
Lilingpeace
Lilingpeace May. 26 at 3:01 PM
$IOVA I am loading up $NYXH, FDA approved, good reimbursement, initial stage of commercialization, currently it’s totally under radar with stock price at 52 weeks low. Its revenue forecast for 2026 is about $36-40M, sequential growth 25-30%,market cap $120M. It is major and only competitor to $INSP, with billion dollar TAM. The only risk is cash burn and needs to have capital raise. Can anyone here please do some DD to see if you think it’s a viable investment?
4 · Reply
Lilingpeace
Lilingpeace May. 26 at 3:00 PM
$VCEL I am loading up $NYXH, FDA approved, good reimbursement, initial stage of commercialization, currently it’s totally under radar with stock price at 52 weeks low. Its revenue forecast for 2026 is about $36-40M, sequential growth 25-30%,market cap $120M. It is major and only competitor to $INSP, with billion dollar TAM. The only risk is cash burn and needs to have capital raise. Can anyone here do some DD to see if you think it’s a viable investment?
0 · Reply
BioGem
BioGem May. 24 at 10:01 PM
$INSP This is shortable around 44$. Extremely overpriced (P/E is 80), with many critical negatives: -Drastic cut in revenue guidance (and worse losses); When low numbers through 2026 come out as guided, the market will digest them and drop it much lower. -Uncertainty will continue until 2028, and even then, it is not assured that reimbursement will be accepted. -Product will be obsolete with soon-to-come powerful weight loss drugs. -Tough competition from similar products already on the market. -Across the board deep cut by analysts. -Multiple class action lawsuits = high lawyers' costs. -High short interest = consensus of lower stock in the near term.
0 · Reply
nUme22
nUme22 May. 22 at 1:44 PM
$INSP 100 EOY. This has such low float that price is not changing much. Tutes controls it. But it wont stay down once the coding issue is resolved
0 · Reply
RocketThief
RocketThief May. 21 at 5:17 PM
$INSP added a bit
0 · Reply
ThePhillySpecial
ThePhillySpecial May. 13 at 5:22 PM
$INSP steaming pile of shit
0 · Reply
WallStJesus
WallStJesus May. 7 at 2:54 PM
$INSP CAUTIOUS ANALYST COMMENTS
1 · Reply
WorldShakerLuke
WorldShakerLuke May. 6 at 10:24 AM
$INSP https://www.foxnews.com/health/sleep-apnea-may-quietly-changing-your-body-unexpected-way-study-finds
0 · Reply
CasInvestments
CasInvestments May. 5 at 2:59 PM
$INSP Most investors don’t have the patience. The uncertainty gives you an advantage to buy at these prices while coding resolves in a year. Meanwhile all of inspires “competition” who planed on launching or launch recently, won’t survive this. Inspire with the best tech, years worth of cash on hand, will come out of this stronger. Once coding is resolved this could quickly get back to $250+ level.
0 · Reply
Latest News on INSP
Piper downgrades Inspire Medical to Neutral on guidance cut

2026-05-05T10:48:49.000Z - 25 days ago

Piper downgrades Inspire Medical to Neutral on guidance cut


Inspire Medical price target lowered to $50 from $63 at Baird

2026-05-05T10:29:43.000Z - 25 days ago

Inspire Medical price target lowered to $50 from $63 at Baird


Inspire Medical downgraded to Neutral from Buy at BofA

2026-05-05T09:45:20.000Z - 25 days ago

Inspire Medical downgraded to Neutral from Buy at BofA


Inspire Medical Systems Earnings Call Transcript: Q1 2026

May 4, 2026, 5:00 PM EDT - 26 days ago

Inspire Medical Systems Earnings Call Transcript: Q1 2026


Inspire Medical Systems Earnings release: Q1 2026

May 4, 2026, 5:00 PM EDT - 26 days ago

Inspire Medical Systems Earnings release: Q1 2026


Inspire Medical Systems Quarterly report: Q1 2026

May 4, 2026, 5:00 PM EDT - 26 days ago

Inspire Medical Systems Quarterly report: Q1 2026


Inspire Medical Systems Slides: Q1 2026

May 4, 2026, 5:00 PM EDT - 26 days ago

Inspire Medical Systems Slides: Q1 2026


Inspire Medical Systems Transcript: AGM 2026

Apr 30, 2026, 9:00 AM EDT - 4 weeks ago

Inspire Medical Systems Transcript: AGM 2026


Inspire Medical Systems Proxy statement: Proxy filing

Mar 20, 2026, 8:00 AM EDT - 2 months ago

Inspire Medical Systems Proxy statement: Proxy filing


Inspire Medical Systems Proxy statement: Proxy filing

Mar 20, 2026, 8:00 AM EDT - 2 months ago

Inspire Medical Systems Proxy statement: Proxy filing


Inspire Medical Systems Proxy statement: Proxy Filing

Mar 9, 2026, 8:00 AM EDT - 2 months ago

Inspire Medical Systems Proxy statement: Proxy Filing


Inspire Medical Systems Earnings Call Transcript: Q4 2025

Feb 11, 2026, 5:00 PM EST - 3 months ago

Inspire Medical Systems Earnings Call Transcript: Q4 2025


Inspire Medical Systems Annual report: Q4 2025

Feb 11, 2026, 5:00 PM EST - 3 months ago

Inspire Medical Systems Annual report: Q4 2025


Inspire Medical Systems Earnings release: Q4 2025

Feb 11, 2026, 5:00 PM EST - 3 months ago

Inspire Medical Systems Earnings release: Q4 2025


Inspire Medical Systems Slides: Q4 2025

Feb 11, 2026, 5:00 PM EST - 3 months ago

Inspire Medical Systems Slides: Q4 2025


Impulse Dynamics® Announces New Chief Financial Officer

Jan 13, 2026, 9:00 AM EST - 4 months ago

Impulse Dynamics® Announces New Chief Financial Officer

SI


Inspire Medical: Buy Or Sell INSP Stock After Its 30% Rally?

Nov 25, 2025, 9:35 AM EST - 6 months ago

Inspire Medical: Buy Or Sell INSP Stock After Its 30% Rally?


nUme22
nUme22 May. 29 at 7:20 PM
$INSP buying
0 · Reply
Lilingpeace
Lilingpeace May. 26 at 3:01 PM
$IOVA I am loading up $NYXH, FDA approved, good reimbursement, initial stage of commercialization, currently it’s totally under radar with stock price at 52 weeks low. Its revenue forecast for 2026 is about $36-40M, sequential growth 25-30%,market cap $120M. It is major and only competitor to $INSP, with billion dollar TAM. The only risk is cash burn and needs to have capital raise. Can anyone here please do some DD to see if you think it’s a viable investment?
4 · Reply
Lilingpeace
Lilingpeace May. 26 at 3:00 PM
$VCEL I am loading up $NYXH, FDA approved, good reimbursement, initial stage of commercialization, currently it’s totally under radar with stock price at 52 weeks low. Its revenue forecast for 2026 is about $36-40M, sequential growth 25-30%,market cap $120M. It is major and only competitor to $INSP, with billion dollar TAM. The only risk is cash burn and needs to have capital raise. Can anyone here do some DD to see if you think it’s a viable investment?
0 · Reply
BioGem
BioGem May. 24 at 10:01 PM
$INSP This is shortable around 44$. Extremely overpriced (P/E is 80), with many critical negatives: -Drastic cut in revenue guidance (and worse losses); When low numbers through 2026 come out as guided, the market will digest them and drop it much lower. -Uncertainty will continue until 2028, and even then, it is not assured that reimbursement will be accepted. -Product will be obsolete with soon-to-come powerful weight loss drugs. -Tough competition from similar products already on the market. -Across the board deep cut by analysts. -Multiple class action lawsuits = high lawyers' costs. -High short interest = consensus of lower stock in the near term.
0 · Reply
nUme22
nUme22 May. 22 at 1:44 PM
$INSP 100 EOY. This has such low float that price is not changing much. Tutes controls it. But it wont stay down once the coding issue is resolved
0 · Reply
RocketThief
RocketThief May. 21 at 5:17 PM
$INSP added a bit
0 · Reply
ThePhillySpecial
ThePhillySpecial May. 13 at 5:22 PM
$INSP steaming pile of shit
0 · Reply
WallStJesus
WallStJesus May. 7 at 2:54 PM
$INSP CAUTIOUS ANALYST COMMENTS
1 · Reply
WorldShakerLuke
WorldShakerLuke May. 6 at 10:24 AM
$INSP https://www.foxnews.com/health/sleep-apnea-may-quietly-changing-your-body-unexpected-way-study-finds
0 · Reply
CasInvestments
CasInvestments May. 5 at 2:59 PM
$INSP Most investors don’t have the patience. The uncertainty gives you an advantage to buy at these prices while coding resolves in a year. Meanwhile all of inspires “competition” who planed on launching or launch recently, won’t survive this. Inspire with the best tech, years worth of cash on hand, will come out of this stronger. Once coding is resolved this could quickly get back to $250+ level.
0 · Reply
ripster47
ripster47 May. 5 at 1:41 PM
$INSP | BofA Securities Downgrades Inspire Medical Systems to Neutral, PT $53 Growth uncertainty and multiple headwinds drive downgrade and sharp PT cut 🔹 Follow @tenet_research for more analyst insights on Other Tickers!
0 · Reply
phonystark
phonystark May. 5 at 1:29 PM
$INSP us well rested cyborgs will have the last laugh
0 · Reply
GetVector
GetVector May. 5 at 12:55 PM
Vector Intelligence (VI) is an algorithm designed to predict potential outsized intraday moves. VI will select up to 4 stocks per day. Today's VI stocks: $BRBR, $CYTK, $DOCN, $INSP.
0 · Reply
PanicSeller8
PanicSeller8 May. 5 at 9:56 AM
$INSP I'm uninspired.
0 · Reply
Arcides
Arcides May. 5 at 2:44 AM
$INSP "bargain" hunters who were joyful for buying at 87 after aug gap down must be happier now that is beter "bargain"
1 · Reply
runitback349
runitback349 May. 5 at 12:39 AM
$INSP garbage on the way to bankruptcy
0 · Reply
aliliimr
aliliimr May. 4 at 9:23 PM
$INSP not so “inspiring” er 😀
0 · Reply
SerbianSU
SerbianSU May. 4 at 8:59 PM
$INSP this company is scam lol.."due to coding issue"....sure
1 · Reply
RazorbackAJ
RazorbackAJ May. 4 at 8:57 PM
$INSP Bad results and shorting here with current trailing stops at $54. Follow for setups like this — exact entries, precise stop levels, nothing vague. This is how I trade, not financial advice.
0 · Reply
Squidward_Tennisballs
Squidward_Tennisballs May. 4 at 8:34 PM
$INSP Jesus they couldn’t offer one bit of good news. Fucking terrible
0 · Reply
nUme22
nUme22 May. 4 at 8:22 PM
$INSP all investors here has been -
0 · Reply
Olivia_Strickland
Olivia_Strickland May. 4 at 8:19 PM
$INSP -15.35% AH to 46.42 is the Q1 print plus the 2026 guide update landing rough, guide revision on a name already -50% YTD and 72% off highs tells you the Street wasn't pricing in another cut. Sleep apnea growth story is getting re-rat Source: https://tapeboard.com/chart/INSP
0 · Reply